ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

Biophysics at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

27 organizations at ELRIG Drug Discovery 2026 present work in biophysics: 20 technology and service providers, 4 drug developers and 3 academic, government and non-profit bodies. Between them they bring 32 presentations to the program. Most represented: AstraZeneca (11 on the program), GSK (8 on the program), Domainex (1 on the program). As of Oct 8, 2026.

All 388 organizations at ELRIG Drug Discovery 2026 →

Showing 1–11 of 27 organizations

Organization	ELRIG Drug Discovery 2026 Attendance
AstraZeneca Cambridge, UK	◆Partner
astrazeneca.com Large pharmaPartner Global biopharmaceutical company discovering and developing medicines in oncology, rare disease, and cardiovascular, renal, metabolic and respiratory disease.	Booth Exhibiting at Booth CZ01 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - CRISPR/Cas technologies from discovery to therapeutic application How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next. Tech Theatre with The Francis Crick Institute Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with Domainex Talk Wed Oct 14 11:20am–11:50am From Design Space to Data Space: An AI-Driven Approach to Better Cell Models and Smarter Assays Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 11:50am–12:20pm Automating In Vivo Antibody Discovery How a manual B-cell processing workflow was automated to reduce operator variability and raise throughput while preserving cell quality. Exhibition Hall Theatre with Hamilton Talk Wed Oct 14 12:20pm–12:50pm Finding Small Molecule Tools in Compound Pools using Surface Plasmon Resonance Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:40pm–3:10pm Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands Auditorium 3 Targeted potency: Advances in radioligands and bioconjugates Talk Wed Oct 14 3:10pm–3:45pm To PhD or not to PhD? Navigating Life Sciences careers as an ECP Whether early career scientists gain more from a doctorate or from hands-on experience, and how people actually build life science careers. Learning Zone Panel Wed Oct 14 4:30pm–5:00pm Panel session - The Future of AI and Design of Experiments in Drug Discovery Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with Cambridge Consultants, IQVIA Talk Wed Oct 14 4:30pm–5:00pm Rewriting Disease-Causing Variants: Templated Editing In Vivo Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 12:40pm–1:10pm The AstraZeneca Global Cell Bank: Powering Consistent and Compliant Drug Discovery Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery Talk Thu Oct 15 3:30pm–4:00pm (AI)straZeneca: Case Studies in the Integration of Machine Learning and Medicinal Chemistry Auditorium 3 AI in medicinal chemistry
GSK London, UK	◆Partner
gsk.com Large pharmaPartner Global biopharmaceutical company developing vaccines and specialty medicines in infectious disease, HIV, respiratory, immunology and oncology.	Booth Exhibiting at Booth CZ02 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Engineering the cell microenvironment: Cell-based models for drug discovery How engineered cell surroundings, from three-dimensional cultures to immune-competent models, help lab assays better predict what happens in patients. Auditorium 1 with Nottingham Trent University Talk Wed Oct 14 11:20am–11:50am Biophysics: A Look Back at Changing Tools and Changing Questions Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:00pm–2:30pm Designing Smarter Experiments: Connecting DoE, Laboratory Automation and AI in a Translational Discovery Workflow Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 2:00pm–2:30pm Sarcoma patient derived 3D cell culture models for drug discovery and prediction of the clinical trials outcome Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 2:40pm–3:10pm Patient-Derived Intestinal Organoids: Advancing Gut Complexity for Drug Discovery and Development Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 5:30pm–6:30pm Early Career Professionals: Network Like A Boss Meeting other early career professionals in speed networking rounds to build the contacts a drug discovery career depends on. Learning Zone with Liverpool School of Tropical Medicine Panel Thu Oct 15 9:30am–10:15am Keynote Panel - 20 Years of Discovery: Lessons from the Past, Blueprints for the Next 20 What two decades of change in drug discovery, from high-throughput screening to AI design, teach about building the next generation of medicines. Auditorium 1 with Constructive Bio, Omega Funds, OtoImmune +1 more Talk Thu Oct 15 2:30pm–3:00pm Automated Molecular Design in BRADSHAW: Application to GSK Projects Auditorium 3 AI in medicinal chemistry
Domainex Cambridge, UK
domainex.co.uk CROs & CDMOs Integrated drug discovery services partner covering target expression, hit identification and lead optimisation through to preclinical candidates.	Booth Exhibiting at Booth J34 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with AstraZeneca Talk Wed Oct 14 2:30pm–2:35pm Technology Spotlight Exhibition Hall Theatre Translating ideas into therapies - Navigating the challenges
Carterra Salt Lake City, Utah	◆Conference Partner
carterra-bio.com Instruments & automationConference Partner Makes high-throughput SPR platforms (LSA, LSA-XT, Ultra, Vega) for label-free screening and characterisation of large and small molecules.	Booth Exhibiting at Booth G08 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 11:50am–12:20pm HT-SPR Technology as a Data Engine for AI-Driven Drug Design How high-throughput surface plasmon resonance binding measurements can generate the large, consistent datasets that train AI models for drug design. Auditorium 4
CERM, University of Florence Florence, Italy
cerm.unifi.it Academic & healthcare Magnetic resonance centre of the University of Florence and a major NMR infrastructure for structural biology, including in-cell NMR.	Talk Wed Oct 14 2:40pm–3:10pm In-cell NMR: a powerful approach for drug discovery Auditorium 4 Next-gen biophysics
Ellison Institute of Technology Oxford, UK
eit.org Academic & healthcare Oxford research institute translating science into solutions in health, food, climate and AI, including a Generative Biology Institute.	Talk Wed Oct 14 4:30pm–5:00pm Combining high throughput native MS screening with synthetic biology to target intricate proteins Auditorium 4 Next-gen biophysics
University of Manchester Manchester, UK
manchester.ac.uk Academic & healthcare Public research university in Manchester.	Talk Wed Oct 14 2:00pm–2:30pm In situ HDX-MS of membrane proteins for drug discovery Auditorium 4 Next-gen biophysics
Unnatural Products Santa Cruz, CA
unnaturalproducts.com Biotech Develops synthetic macrocyclic peptide drugs aiming for antibody-like potency and selectivity with oral delivery.	Talk Wed Oct 14 3:45pm–4:15pm Macrocyclic peptides achieving antibody-like potency and selectivity with oral delivery: A focus on biophysical techniques for highly potent compounds Auditorium 4 Next-gen biophysics
Evotec Hamburg, Germany
evotec.com CROs & CDMOs Drug discovery and development partner offering CRO and CDMO services, integrated programs and strategic partnerships from target to clinic.	Booth Exhibiting at Booth C33 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 12:05pm–12:20pm A Transcriptomics‑AI Framework for Early Detection and De‑Risking of Nephrotoxicity How gene activity readouts combined with machine learning flagged kidney-damaging compounds early and pointed to the mechanisms behind the injury. Auditorium 1 Talk Wed Oct 14 4:15pm–4:30pm Biosensor based screening of large lead like chemical libraries in pools - an alternative biophysical approach for hit identification in small molecule drug discovery Screening large pools of lead-like compounds with surface plasmon resonance and related biosensors to find direct binders and measure their binding behaviour. Auditorium 4
Bruker Billerica, Massachusetts
bruker.com Instruments & automation Showing its biosensor range: SPR systems, switchSENSE and single-cell interaction cytometry for measuring binding kinetics, including on living cells.	Booth Exhibiting at Booth K14 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 12:50pm–12:55pm Technology Spotlight Auditorium 4 Next-gen biophysics
Cube Biotech Monheim am Rhein, Germany
cube-biotech.com Reagents, assays & models Membrane protein specialist offering copolymer stabilization reagents, protein production, and biophysical and cryo-EM structural services.	Booth Exhibiting at Booth K09 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 2:30pm–2:35pm Technology Spotlight Auditorium 4 Next-gen biophysics